Cell therapy for stroke: remaining issues to address before embarking on clinical trials.
about
Permeating the blood brain barrier and abrogating the inflammation in stroke: implications for stroke therapyStem cell therapy for neonatal hypoxic-ischemic encephalopathyTherapeutic effects of hMAPC and hMSC transplantation after stroke in miceFate of graft cells: what should be clarified for development of mesenchymal stem cell therapy for ischemic stroke?THE CASE FOR AN ETHICS RESEARCH CONSORTIUM FOR EMERGING TECHNOLOGIES: PUBLIC PERCEPTION OF STEM CELL RESEARCH AND DEVELOPMENTIntracarotid administration of human bone marrow mononuclear cells in rat photothrombotic ischemia.Transplanted bone marrow stem cells relocate to infarct penumbra and co-express endogenous proliferative and immature neuronal markers in a mouse model of ischemic cerebral strokeBone marrow stromal cells increase oligodendrogenesis after strokeNeural stem cell protects aged rat brain from ischemia-reperfusion injury through neurogenesis and angiogenesis.Therapeutic outcomes of transplantation of amniotic fluid-derived stem cells in experimental ischemic stroke.An Update on Translating Stem Cell Therapy for Stroke from Bench to Bedside.Implantation site and lesion topology determine efficacy of a human neural stem cell line in a rat model of chronic stroke.Intravenous grafts of amniotic fluid-derived stem cells induce endogenous cell proliferation and attenuate behavioral deficits in ischemic stroke rats.Preclinical assessment of stem cell therapies for neurological diseases.Stem cell-like dog placenta cells afford neuroprotection against ischemic stroke model via heat shock protein upregulation.Baby STEPS: a giant leap for cell therapy in neonatal brain injuryBehavioral and histopathological assessment of adult ischemic rat brains after intracerebral transplantation of NSI-566RSC cell linesCombining BMI Stimulation and Mathematical Modeling for Acute Stroke Recovery and Neural RepairMenstrual blood cells display stem cell-like phenotypic markers and exert neuroprotection following transplantation in experimental stroke.The great migration of bone marrow-derived stem cells toward the ischemic brain: therapeutic implications for stroke and other neurological disordersMeeting report of the first conference of the International Placenta Stem Cell Society (IPLASS).ADVANCES IN THE CELL-BASED TREATMENT OF NEONATAL HYPOXIC-ISCHEMIC BRAIN INJURYIn vivo animal stroke models: a rationale for rodent and non-human primate models.The emerging role of epigenetics in stroke: III. Neural stem cell biology and regenerative medicine.Stem cell transplantation for neuroprotection in stroke.Advancing critical care medicine with stem cell therapy and hypothermia for cerebral palsy.Breaking the barrier in stroke: what should we know? A mini-review.Stem Cells for Neurovascular Repair in Stroke.Magnetic manipulation of bacterial magnetic nanoparticle-loaded neurospheres.Stem cell therapy for abrogating stroke-induced neuroinflammation and relevant secondary cell death mechanisms.Alginate encapsulated human mesenchymal stem cells suppress syngeneic glioma growth in the immunocompetent rat.Striatal stimulation nurtures endogenous neurogenesis and angiogenesis in chronic-phase ischemic stroke rats.Bone marrow-derived endothelial progenitor cells protect postischemic axons after traumatic brain injury.Delayed Umbilical Cord Blood Clamping: First Line of Defense Against Neonatal and Age-Related Disorders.Intravenously Transplanted Human Bone Marrow Endothelial Progenitor Cells Engraft Within Brain Capillaries, Preserve Mitochondrial Morphology, and Display Pinocytotic Activity Toward Blood-Brain Barrier Repair in Ischemic Stroke Rats.
P2860
Q26865517-4531DB52-ECD8-490E-B06E-988831A8C2B6Q27003906-7BEBFD33-76D1-4EC0-9DE2-A3CEFE312A9BQ27322703-9D56CC14-C038-4C19-9217-DB72E28A2604Q27692601-EFC344BE-FE73-4FAD-99F0-4002791F71BAQ30433137-FD5F0416-EE0E-47ED-BA8B-9E4A1A822AF1Q33687659-EC511725-2C6B-49B1-9E9D-653868B1B19BQ33727333-AFBB14B8-F215-402E-BC1A-13D388193DEFQ33769799-F2AE4A08-6704-4E61-8037-B34492816BF0Q33851455-15868450-AB42-4E8F-89C6-1D16316E6493Q34038582-2EAE9F78-6DD7-46CF-BF4B-7E5CF4C8ABE7Q34107076-F251EED5-78D2-483B-8B88-2DA5ACE660FCQ34115945-EBD61D77-A271-4732-90CA-962FF6504677Q34389750-F7B25C32-49D0-4708-BB1A-5AC82A4ED971Q34786764-005D186D-06E3-4701-A3AF-142D40B1DD87Q35006313-FF8EE1E5-0F31-4D04-9F44-5F0F95870FF8Q35051518-CD7EEA44-E212-479B-8E93-32AB6922D941Q35116680-96A97709-0FA3-41B2-AA87-F742C14023A6Q35130257-75AEA106-2639-42B8-912A-7369335DB84BQ35171618-8676A4D1-F5E0-4562-968E-19CDC5825153Q35256491-3ADAF810-13B1-49CF-8C15-FC709061B1FDQ35624272-571B30D2-7486-47B4-A51B-0E76D014AAB0Q36737627-A9D81A18-16F9-4C52-947A-39D3DA84F48FQ36839215-B0D040ED-52F6-49C6-91AD-517C3FF165DCQ36898956-E2DDEEAF-65BB-496A-A3CE-4C8A95A80D6AQ37238494-CAB3F401-B69D-4FDD-93EC-347AEF9742A6Q37470229-F273D7AB-9BFE-4C6C-9E6D-A827E5A53035Q38009070-F36150EA-C36B-4983-BDE5-7235D46E6363Q38146735-F6456C8B-4A9E-4318-A2E9-B582D5722A70Q39014531-61992EDD-14E1-4787-932A-965D52F1684FQ39457984-12785064-8C01-4130-AAFF-22EEB39A7184Q39505071-2CDFAA67-B870-418F-A672-1D08F1E5B320Q39629641-A5D769AF-FC56-4ED4-8641-B002753238A7Q41820291-269B2F1F-E873-4EDC-91E5-0BC9BA8C0B82Q41907085-47C48E19-646E-4A0B-8D57-2424492EFACBQ48331191-FAC8ACEE-F7E2-40B4-815F-01484708BA7D
P2860
Cell therapy for stroke: remaining issues to address before embarking on clinical trials.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Cell therapy for stroke: remaining issues to address before embarking on clinical trials.
@ast
Cell therapy for stroke: remaining issues to address before embarking on clinical trials.
@en
type
label
Cell therapy for stroke: remaining issues to address before embarking on clinical trials.
@ast
Cell therapy for stroke: remaining issues to address before embarking on clinical trials.
@en
prefLabel
Cell therapy for stroke: remaining issues to address before embarking on clinical trials.
@ast
Cell therapy for stroke: remaining issues to address before embarking on clinical trials.
@en
P2860
P1433
P1476
Cell therapy for stroke: remaining issues to address before embarking on clinical trials.
@en
P2093
Cesar V Borlongan
P2860
P304
P356
10.1161/STROKEAHA.108.533091
P407
P433
P577
2008-12-08T00:00:00Z